Michael Oelgeschläger

Christopher Weidner¹, 

Matthias Steinfath¹, 

Elisa Wistorf¹, 

Michael Oelgeschläger¹, 

Marlon R. Schneider¹, 

Gilbert Schönfelder^1,2 

¹Department of Experimental Toxicology and ZEBET, German Federal Institute for Risk Assessment (BfR), 

²Department of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin